Ibrutinib's metabolism by CYP3A makes it susceptible to drug interactions, affecting its serum concentration significantly with CYP3A modulators. Despite frequent drug interactions, overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results